Mel J. Yeates
This person does not yet have a bio.
Articles by Mel J. Yeates
| 3 min read
Purdue researchers apply machine learning concepts to create a new mass spec method
| 4 min read
PepTC reports positive preclinical results for peptide vaccine
| 3 min read
Hoth Therapeutics collaborates with USAMRDC to treat multi-drug resistant bacterial lung infections
| 2 min read
In lab experiments, pralatrexate outperformed remdesivir against SARS-CoV-2
| 3 min read
Altimmune begins Phase 2 clinical trial of HepTcell, an immunotherapeutic for chronic hepatitis B
| 3 min read
The companies will collaborate on an allogeneic cell therapy candidate for solid tumor cancers
| 2 min read
AMG 634, an investigational treatment for tuberculosis and leprosy, has been licensed to Medicines Development for Global Health
| 3 min read
NBE-Therapeutics will remain at its Basel, Switzerland, campus and operate within Boehringer Ingelheim’s R&D network
| 2 min read
Kineta doses first patient in Phase 1 trial of KCP506, a non-opioid treatment for chronic pain
| 3 min read
New insights into age-related macular degeneration could lead to better treatments
| 2 min read
Researchers have discovered that SIGLEC12 contains several features unique to humans
| 3 min read
PhaseBio doses the first patients in Canada with its antiplatelet activity reversal therapy
